Skip to Content

A-17.5 mg A-17.5 mg (Soriatane 17.5 mg)

Generic Name: acitretin

Pill with imprint A-17.5 mg A-17.5 mg is Yellow, Capsule-shape and has been identified as Soriatane 17.5 mg. It is supplied by GlaxoSmithKline.

Soriatane is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Soriatane 17.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A-17.5 mg A-17.5 mg

Soriatane

Generic Name:
acitretin
Imprint:
A-17.5 mg A-17.5 mg
Strength:
17.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antipsoriatics
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
microcrystalline cellulose
sodium ascorbate
gelatin
maltodextrin
ferric oxide yellow
ferrosoferric oxide
ferric oxide red
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide